Skip to content

Safety and efficacy of bupivacaine liposome in serratus anterior plane block

Safety and efficacy of bupivacaine liposome in serratus anterior plane block

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300076281
Enrollment
Unknown
Registered
2023-09-28
Start date
2023-10-01
Completion date
Unknown
Last updated
2023-10-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pain after thoracic surgery

Interventions

RPB:Subjects underwent deep frontal serratus plane block with 0.375% ropivacaine in combination with an opioid analgesic pump for postoperative analgesia
LBB:Participants used 0.665% bupivacaine liposomes for deep serratus plane block for postoperative analgesia

Sponsors

The First Affiliated Hospital of Nanchang University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1) the patients who intend to undergo thoracoscopic lobectomy are the same group of doctors. 2) male or female, aged 18-65 3) male weight = 50, female weight = 45, BMI19.0~26.0kg/m2 4) ASA rating of anesthesia is grade ? ~ ?. 5) before the test, have a detailed understanding of the nature, significance, possible benefits, possible inconvenience and potential danger, understand the research procedure and sign the informed consent form voluntarily in writing.

Exclusion criteria

Exclusion criteria: 1) the patient refused to perform anterior serratus plane block. 2) the patient has specific allergic diseases (asthma, urticaria, eczema, etc.) or is known to be allergic to bupivacaine 3) the area of the anterior chest wall of the patient is damaged or infected. 4) the coagulation function of the patient was abnormal, APTT > 33.8S or PT > 12.1s before operation. 5) the patient has a history of chronic neuropathic pain. 6) patients participate in other clinical trials at the same time.

Design outcomes

Primary

MeasureTime frame
postoperative pain;

Secondary

MeasureTime frame
quality of recovery;Time to first use of analgesics;Extubation time;Serum concentrations of TNF-a, IL-1ß and IL-6 were measured.;ICU dwell time;Time to first exhaust bowel movements;Incidence of postoperative pruritus;the first time of out of bed;Postoperative opioid analgesic use;Incidence of postoperative nausea and vomiting;Length of hospital stay;hospitalization expenses;Quality of sleep after surgery;Perioperative satisfaction;Adverse event rate;

Countries

China

Contacts

Public ContactChen Shibiao

The First Affiliated Hospital of Nanchang University

ndyfy00763@ncu.edu.cn+86 138 7098 2918

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026